Cargando…

The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells

Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression i...

Descripción completa

Detalles Bibliográficos
Autores principales: Macanas-Pirard, Patricia, Quezada, Thomas, Navarrete, Leonardo, Broekhuizen, Richard, Leisewitz, Andrea, Nervi, Bruno, Ramírez, Pablo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207636/
https://www.ncbi.nlm.nih.gov/pubmed/28045930
http://dx.doi.org/10.1371/journal.pone.0168888
_version_ 1782490402896478208
author Macanas-Pirard, Patricia
Quezada, Thomas
Navarrete, Leonardo
Broekhuizen, Richard
Leisewitz, Andrea
Nervi, Bruno
Ramírez, Pablo A.
author_facet Macanas-Pirard, Patricia
Quezada, Thomas
Navarrete, Leonardo
Broekhuizen, Richard
Leisewitz, Andrea
Nervi, Bruno
Ramírez, Pablo A.
author_sort Macanas-Pirard, Patricia
collection PubMed
description Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression in AML cell lines and primary AML cells by flow cytometry (FCM), real time PCR (RT-PCR) and western blot (WB). CCL2 production was quantified by solid phase ELISA in peripheral blood (PB) and bone marrow (BM) serum. We measured chemotaxis in a transwell system with different concentrations of CCL2/CCR2 blockers; cell cycle with BrDU and propidium iodide and proliferation with yellow tetrazolium MTT. We determined synergy in in vitro cell apoptosis combining chemotherapy and CCL2/CCR2 blockade. Finally, we performed chemoprotection studies in an in vivo mouse model. Of 35 patients, 23 (65%) expressed CCR2 by FCM in PB. Two cell lines expressed high levels of CCR2 (THP-1 and murine AML). RT-PCR and WB confirmed CCR2 production. CCL2 solid phase ELISA showed significantly lower levels of CCL2 in PB and BM compared to normal controls. Chemotaxis experiments confirmed a dose-dependent migration in AML primary cells expressing CCR2 and THP-1 cells. A significant inhibition of transmigration was seen after CCL2/CCR2 blockade. Proliferation of CCR2+ AML cell lines was slightly increased (1.4-fold) after axis stimulation. We observed a non-significant increase in phase S THP-1 cells exposed to CCL2 and a concomitant decrease of cells in G1. The chemotherapy studies did not show a protective effect of CCL2 on cytarabine-induced apoptosis or synergy with chemotherapy after CCL2/CCR2 blockade both in vitro and in vivo. In conclusion, CCL2/CCR2 axis is expressed in the majority of monocytoid AML blasts. The axis is involved in cell trafficking and proliferation but no in vitro and in vivo chemotherapy protective effect was seen.
format Online
Article
Text
id pubmed-5207636
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52076362017-01-19 The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells Macanas-Pirard, Patricia Quezada, Thomas Navarrete, Leonardo Broekhuizen, Richard Leisewitz, Andrea Nervi, Bruno Ramírez, Pablo A. PLoS One Research Article Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression in AML cell lines and primary AML cells by flow cytometry (FCM), real time PCR (RT-PCR) and western blot (WB). CCL2 production was quantified by solid phase ELISA in peripheral blood (PB) and bone marrow (BM) serum. We measured chemotaxis in a transwell system with different concentrations of CCL2/CCR2 blockers; cell cycle with BrDU and propidium iodide and proliferation with yellow tetrazolium MTT. We determined synergy in in vitro cell apoptosis combining chemotherapy and CCL2/CCR2 blockade. Finally, we performed chemoprotection studies in an in vivo mouse model. Of 35 patients, 23 (65%) expressed CCR2 by FCM in PB. Two cell lines expressed high levels of CCR2 (THP-1 and murine AML). RT-PCR and WB confirmed CCR2 production. CCL2 solid phase ELISA showed significantly lower levels of CCL2 in PB and BM compared to normal controls. Chemotaxis experiments confirmed a dose-dependent migration in AML primary cells expressing CCR2 and THP-1 cells. A significant inhibition of transmigration was seen after CCL2/CCR2 blockade. Proliferation of CCR2+ AML cell lines was slightly increased (1.4-fold) after axis stimulation. We observed a non-significant increase in phase S THP-1 cells exposed to CCL2 and a concomitant decrease of cells in G1. The chemotherapy studies did not show a protective effect of CCL2 on cytarabine-induced apoptosis or synergy with chemotherapy after CCL2/CCR2 blockade both in vitro and in vivo. In conclusion, CCL2/CCR2 axis is expressed in the majority of monocytoid AML blasts. The axis is involved in cell trafficking and proliferation but no in vitro and in vivo chemotherapy protective effect was seen. Public Library of Science 2017-01-03 /pmc/articles/PMC5207636/ /pubmed/28045930 http://dx.doi.org/10.1371/journal.pone.0168888 Text en © 2017 Macanas-Pirard et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Macanas-Pirard, Patricia
Quezada, Thomas
Navarrete, Leonardo
Broekhuizen, Richard
Leisewitz, Andrea
Nervi, Bruno
Ramírez, Pablo A.
The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
title The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
title_full The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
title_fullStr The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
title_full_unstemmed The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
title_short The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
title_sort ccl2/ccr2 axis affects transmigration and proliferation but not resistance to chemotherapy of acute myeloid leukemia cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207636/
https://www.ncbi.nlm.nih.gov/pubmed/28045930
http://dx.doi.org/10.1371/journal.pone.0168888
work_keys_str_mv AT macanaspirardpatricia theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT quezadathomas theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT navarreteleonardo theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT broekhuizenrichard theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT leisewitzandrea theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT nervibruno theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT ramirezpabloa theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT macanaspirardpatricia ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT quezadathomas ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT navarreteleonardo ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT broekhuizenrichard ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT leisewitzandrea ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT nervibruno ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells
AT ramirezpabloa ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells